Monday, May 27, 2024
Home > Uncategorized > France’s Sanofi to create an active pharmaceutical ingredients business

France’s Sanofi to create an active pharmaceutical ingredients business


The logo of Sanofi is seen at the company’s research and production centre in Vitry-sur-Seine, France, August 6, 2019.

Charles Platiau | Reuters

French drugmaker Sanofi said on Monday it would create the business on the back of the combination of its API commercial and development activities with six of its European API production sites in Italy, Germany, Britain, France and Hungary.

Europe’s pharmaceutical sector is highly dependent on raw materials and active ingredients from Asia, buying products from companies such as India’s Sun Pharmaceuticals and Aurobindo Pharma.

Sanofi said the new group will be headquartered in France, operate with at least 3,100 skilled employees and have sales estimated at around 1 billion euros ($1.08 billion) by 2022.

“Sanofi is fully committed to the new company’s success and intends to establish a long-term customer relationship with the new API supplier and to hold a minority stake of approximately 30% in the new company,” it said in a statement.

France’s CGT union said the announcement was detrimental to staff and was putting the future of factories at risk.

“Clearly, the management is willing to outsource production. Retaining a 30% stake in the new entity is purely to look good,” a spokesman for the union said.


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *